What is Clearstep?
Founded in 2018 and headquartered in Chicago, Illinois, Clearstep operates as a sophisticated AI care navigation platform. The company addresses critical inefficiencies in the healthcare delivery system by intelligently matching patients to appropriate providers based on a comprehensive analysis of symptoms, insurance coverage, and geographic location. By facilitating seamless booking for both in-person and virtual care, Clearstep serves as a vital bridge between patient needs and clinical availability. Its platform is designed to reduce administrative friction, improve patient outcomes, and optimize provider utilization, positioning the firm as a key player in the enterprise-level healthcare technology market.
How much funding has Clearstep raised?
Clearstep has raised a total of $5M across 3 funding rounds:
Private Equity
$120K
Other Financing Round
$1.3M
Angel/Seed
$3.6M
Private Equity (2019): $120K with participation from Techstars
Other Financing Round (2020): $1.3M led by RRE Ventures, Newark Venture Partners, and OCA Ventures
Angel/Seed (2021): $3.6M, investors not publicly disclosed
Key Investors in Clearstep
RRE Ventures
RRE Ventures is a venture capital firm dedicated to supporting founders at critical stages of their business journey, focusing on long-term partnerships and innovative ideas.
Newark Venture Partners
NVP Capital is a leading venture capital firm that specializes in providing early-stage funding and strategic support to innovative startups, particularly in healthcare and technology.
OCA Ventures
OCA Ventures is dedicated to assisting entrepreneurs in the development of successful companies by providing support and resources to help startups thrive in their respective markets.
What's next for Clearstep?
With the recent influx of capital, Clearstep is well-positioned to accelerate its product development roadmap and expand its footprint within the enterprise healthcare ecosystem. The strategic focus will likely center on deepening integration capabilities with existing electronic health record systems and scaling its AI diagnostic accuracy to support a broader range of clinical specialties. As the company transitions from its early-stage development into a more mature scaling phase, the focus will shift toward market penetration and establishing long-term partnerships with large-scale health systems. This strategic expansion is expected to further solidify Clearstep's competitive advantage in the rapidly digitizing healthcare sector.
See full Clearstep company page
